Breaking Prince Harry and Meghan Plan Extended UK Visit This Fall University of Michigan Hosts Seminar on Ancient Papyrus Conservation Historic Steam Tugboat Emerges from Sava River Amidst Severe Drought Prince Harry Highlights Need for Better Veteran Transition to Civilian Careers Emails Reveal U.S. Immigration Collaboration with Iran on Deportations Amidst Conflict

Thursday August 20, 2026

Reporter

InnoCare Pharma

3Articles Published

4Communities Covered

Published Articles

Press Release

InnoCare Announces Approval of Head-to-Head Registrational Phase III Trial of Mesutoclax with Azacitidine versus Venetoclax with Azacitidine in Treatment-Naive AML in China

Aug 18

Press Release

InnoCare Announces Orelabrutinib in Combination with Mesutoclax Granted Breakthrough Therapy Designation in China

Aug 3

Press Release

InnoCare’s TYK2 Inhibitor Fadeucravacitinib (ICP-488) Meets Primary Endpoint in Phase III Psoriasis Study

Jul 27